P. Harari

发表

Image guidance for precise conformal radiotherapy.

J. Fowler, M. Mehta, R. Jeraj, 2003, International journal of radiation oncology, biology, physics.

Adding dose escalation to accelerated hyperfractionation for head and neck cancer: 76 Gy in 5 weeks

P. Harari, 1992 .

Regulation of Heparin-Binding EGF-Like Growth Factor by miR-212 and Acquired Cetuximab-Resistance in Head and Neck Squamous Cell Carcinoma

P. Harari, C. Chung, R. Slebos, 2010, PloS one.

Promising new advances in head and neck radiotherapy.

P. Harari, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck.

Christopher U. Jones, K. Ang, P. Harari, 2006, The New England journal of medicine.

Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival.

Jordi Giralt, Christopher U. Jones, K Kian Ang, 2010, The Lancet. Oncology.

Variations in target delineation for head and neck IMRT: An international multi-institutional study

W. Tomé, P. Harari, T. Hong, 2004 .

The impact of daily setup variations on head-and-neck intensity-modulated radiation therapy.

Prakash Chinnaiyan, Wolfgang A Tomé, M. Mehta, 2005, International journal of radiation oncology, biology, physics.

Heterogeneity in head and neck IMRT target design and clinical practice.

Wolfgang A Tomé, W. Tomé, P. Harari, 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

In Situ Tumor Vaccination by Combining Local Radiation and Tumor-Specific Antibody or Immunocytokine Treatments.

P. Harari, A. Korman, S. Gillies, 2016, Cancer research.

Tumor-Specific Inhibition of In Situ Vaccination by Distant Untreated Tumor Sites

P. Harari, S. Busche, A. Korman, 2018, Cancer Immunology Research.

Combining EGFR inhibitors with radiation or chemotherapy: will preclinical studies predict clinical results?

P. Harari, Shyhmin Huang, 2004, International journal of radiation oncology, biology, physics.

Human organotypic lymphatic vessel model elucidates microenvironment-dependent signaling and barrier function.

D. Beebe, P. Harari, Max M Gong, 2019, Biomaterials.

Enhanced Radiosensitivity in Solid Tumors using a Tumor-selective Alkyl Phospholipid Ether Analog

P. Harari, B. Bednarz, Sorabh Singhal, 2018, Molecular Cancer Therapeutics.

Clinical advancement of EGFR inhibitors in cancer therapy.

P. Harari, P. Chinnaiyan, 2006, Methods in molecular biology.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

Manish R. Patel, Charles J. Vaske, Joe Y. Chang, 2016, Journal for Immunotherapy of Cancer.

Interaction of radiation therapy with molecular targeted agents.

P. Harari, Z. Morris, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

EGFR-targeting monoclonal antibodies in head and neck cancer.

P. Harari, I. Astsaturov, R. Cohen, 2006, Current cancer drug targets.

Head and neck cancer as a clinical model for molecular targeting of therapy: combining EGFR blockade with radiation.

P. Harari, Shyhmin Huang, S. Huang, 2001, International journal of radiation oncology, biology, physics.

Human Tumor‐Lymphatic Microfluidic Model Reveals Differential Conditioning of Lymphatic Vessels by Breast Cancer Cells

D. Beebe, P. Harari, M. Skala, 2020, Advanced healthcare materials.

Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial

Christopher U. Jones, E. Sturgis, P. Harari, 2019, The Lancet.

Multiple daily fractionation radiotherapy schedules in lung cancer

M. Mehta, P. Harari, C. Schulz, 2001, Current oncology reports.

Radiation oncologists can assist head and neck cancer patients with smoking cessation.

M. Fiore, P. Harari, T. Kinsella, 1995, International journal of radiation oncology, biology, physics.

Clinical outcomes for patients presenting with N3 head and neck squamous cell carcinoma: Analysis of the National Cancer Database

P. Harari, M. Witek, A. Baschnagel, 2017, Head & neck.

Are we influencing outcome in oropharynx cancer with intensity-modulated radiotherapy? An inter-era comparison.

P. Harari, S. Bentzen, V. Gondi, 2007, International journal of radiation oncology, biology, physics.

Comprehensive IMRT plus weekly cisplatin for advanced head and neck cancer: The University of Wisconsin experience

P. Harari, S. Bentzen, J. Cleary, 2009, Head & neck.

Head and neck carcinoma in the United States

Amy Y. Chen, D. Hayes, A. Garden, 2012, Cancer.

Angiogenesis and radiation response modulation after vascular endothelial growth factor receptor-2 (VEGFR2) blockade.

J. Fowler, P. Harari, E. Armstrong, 2005, International journal of radiation oncology, biology, physics.

Risk of cerebrovascular events in elderly patients after radiation therapy versus surgery for early-stage glottic cancer.

Julian C. Hong, P. Harari, S. Bentzen, 2013, International journal of radiation oncology, biology, physics.

Peer review program to enhance treatment planning quality assurance for community radiation oncologists

P. Harari, B. Durkee, A. Burr, 2020, Journal of Radiation Oncology.

Cetuximab (Imclone/Merck/Bristol-Myers Squibb).

P. Harari, M. Kies, 2002, Current opinion in investigational drugs.

Modulation of tumor cell proliferation and apoptosis by polyamine depletion in cells of head and neck squamous cell carcinomas.

P. Harari, J. Pink, J. Bock, 1999, Radiation research.

Randomized phase II/III confirmatory treatment selection design with a change of survival end points: Statistical design of Radiation Therapy Oncology Group 1216

P. Harari, Q. Zhang, D. Rosenthal, 2018, Head & neck.

Molecular Target Approaches in Head and Neck Cancer: EGFR and Beyond

J. Grandis, P. Harari, D. Wheeler, 2011 .

Clinical application of EGFR inhibitors in head and neck squamous cell cancer.

P. Harari, I. Astsaturov, R. Cohen, 2008, Cancer treatment and research.

Augmentation of radiation response by panitumumab in models of upper aerodigestive tract cancer.

Daniel J. Freeman, P. Harari, D. Wheeler, 2008, International journal of radiation oncology, biology, physics.

Small cell carcinoma of the head and neck: An analysis of the National Cancer Database.

P. Harari, M. Witek, A. Baschnagel, 2017, Oral oncology.

Prospective Study of PET/MRI Tumor Response During Chemoradiotherapy for Patients With Low-risk and Intermediate-risk p16-positive Oropharynx Cancer

P. Harari, M. Witek, Menggang Yu, 2022, American journal of clinical oncology.

Practice Recommendations for Risk-Adapted Head and Neck Cancer Radiation Therapy During the COVID-19 Pandemic: An ASTRO-ESTRO Consensus Statement

A. Garden, V. Grégoire, K. Harrington, 2020, International Journal of Radiation Oncology*Biology*Physics.

Practice recommendations for risk-adapted head and neck cancer radiotherapy during the COVID-19 pandemic: An ASTRO-ESTRO consensus statement

A. Garden, V. Grégoire, K. Harrington, 2020, Radiotherapy and Oncology.

Reducing radiotherapy target volume expansion for patients with HPV-associated oropharyngeal cancer.

P. Harari, M. Witek, R. Kimple, 2019, Oral oncology.

Is HPV‐Associated Oropharyngeal Cancer Becoming More Common in Older Patients?

P. Harari, G. Hartig, James D. Thompson, 2018, Laryngoscope investigative otolaryngology.

Outcomes for patients with head and neck squamous cell carcinoma presenting with N3 nodal disease

P. Harari, M. Witek, C. Hullett, 2017, Cancers of the Head & Neck.

Assessing p16 Status of Oropharyngeal Squamous Cell Carcinoma by Combined Assessment of the Number of Cells Stained and the Confluence of p16 Staining: A Validation by Clinical Outcomes

P. Harari, David T Yang, P. Mohindra, 2016, The American journal of surgical pathology.

The prognostic value of HPV in head and neck cancer patients undergoing postoperative chemoradiotherapy.

P. Harari, R. Kimple, 2015, Annals of translational medicine.

Increased local failure risk with prolonged radiation treatment time in head and neck cancer treated with concurrent chemotherapy

P. Harari, T. McCulloch, H. Geye, 2014, Head & neck.

Is radiation dose reduction the right answer for HPV-positive head and neck cancer?

P. Harari, R. Kimple, 2014, Oral oncology.

Robotics in head and neck cancer: future opportunities.

P. Harari, G. Hartig, 2010, Oncology.

Incidental Parotid Neoplasms

P. Harari, Andrew P. Stein, G. Hartig, 2015, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

Phase 1 trial of bevacizumab with concurrent chemoradiation therapy for squamous cell carcinoma of the head and neck with exploratory functional imaging of tumor hypoxia, proliferation, and perfusion.

R. Jeraj, P. Harari, T. McCulloch, 2015, International journal of radiation oncology, biology, physics.

Improved preservation of larynx with the addition of cetuximab to radiation for cancers of the larynx and hypopharynx

K. Ang, P. Harari, J. Jassem, 2005 .

Development and Characterization of HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinoma Tumorgrafts

P. Harari, Menggang Yu, P. Lambert, 2012, Clinical Cancer Research.

Applications in Head and Neck Cancer

P. Harari, D. Khuntia, A. Traynor, 2006 .

Longitudinal oncology registry of head and neck carcinoma (LORHAN)

Amy Y. Chen, A. Garden, K. Ang, 2011, Cancer.

Abstract 4495: Sym013, novel pan-HER monoclonal antibody mixture, augments radiation response in human lung and head and neck tumors

P. Harari, I. Horak, M. Kragh, 2014 .

Metabolic Tumor Volume as a Predictive Imaging Biomarker in Head-and-Neck Cancer: Pilot Results From RTOG 0522

A. Garden, P. Harari, D. Schwartz, 2013 .

Radiosensitization following EGFR signaling inhibition by erlotinib (Tarceva

P. Harari, P. Chinnaiyan, E. Armstrong, 2003 .

Planned postradiotherapy neck dissection in patients with advanced head and neck cancer

P. Harari, C. Schultz, R. Foote, 1998, Head & neck.

Influence of Computed Tomography on Pretherapeutic Tumor Staging in Head and Neck Cancer Patients

P. Harari, W. Brown, C. Ford, 1998, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

Radiation Dose Escalation in Esophageal Cancer Revisited: A Contemporary Analysis of the National Cancer Data Base, 2004 to 2012.

P. Harari, M. Ritter, A. Baschnagel, 2016, International journal of radiation oncology, biology, physics.

Longitudinal oncology registry of head and neck carcinoma (LORHAN®): initial supportive care findings

Amy Y. Chen, A. Garden, K. Ang, 2009, Supportive Care in Cancer.

Results From 10 Years of a Free Oral Cancer Screening Clinic at a Major Academic Health Center.

P. Harari, M. Witek, T. McCulloch, 2018, International journal of radiation oncology, biology, physics.

Therapeutic selective neck dissection outcomes

P. Harari, G. Leverson, G. Hartig, 2008, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

A Comprehensive Assessment by Tumor Site of Patient Setup using Daily MVCT Imaging from Over Three Thousand Eight Hundred Helical Tomotherapy Treatments

T. Mackie, W. Tomé, P. Harari, 2009 .

Insulin-like growth factor-I receptor signaling blockade combined with radiation.

P. Harari, D. Hicklin, D. Ludwig, 2007, Cancer research.

Wound healing following combined radiation and cetuximab therapy in head and neck cancer patients.

E. Rosenthal, P. Harari, H. Geye, 2011, Journal of wound care.

Pan-HER receptor inhibition augments radiation response in human lung and head and neck cancer models

P. Harari, C. Hullett, M. Kragh, 2015 .

Molecular inhibition of angiogenesis and metastatic potential in human squamous cell carcinomas after epidermal growth factor receptor blockade.

P. Harari, Shyhmin Huang, Jing Li, 2002, Molecular cancer therapeutics.

Modulation of molecular targets to enhance radiation.

P. Harari, S. Huang, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Radiation and new molecular agents, part II: targeting HDAC, HSP90, IGF-1R, PI3K, and Ras.

P. Harari, P. Chinnaiyan, G. Allen, 2006, Seminars in radiation oncology.

Evolutionary Action Score of TP53 Analysis in Pathologically High-Risk Human Papillomavirus-Negative Head and Neck Cancer From a Phase 2 Clinical Trial: NRG Oncology Radiation Therapy Oncology Group 0234

D. Hayes, O. Lichtarge, I. Wistuba, 2022 .

Adjuvant Therapy for Patients with Oral Cavity Cancer

P. Harari, R. Manon, D. Khuntia, 2009 .

Anti-EGFR therapy update: clinical experience and adverse event insights.

P. Harari, 2006, Oncology.

Multi-institutional Trial of IMRT for Early Stage Oropharyngeal Cancer: Acceleration via Simultaneously Incorporated Boost (SIB) (RTOG 00-22)

Christopher U. Jones, A. Garden, K. Ang, 2008 .

Acute Hematologic and Mucosal Toxicities in Head and Neck Cancer Patients Undergoing Chemoradiotherapy: A Comparison of 3D-CRT, IMRT, and Helical Tomotherapy

W. Tomé, P. Harari, K. Kozak, 2013, Technology in cancer research & treatment.

Life Beyond COVID: Pay Attention to Viruses

P. Harari, P. Lambert, 2020, International Journal of Radiation Oncology*Biology*Physics.

Squamous Cell Carcinomas of the Head and Neck Modulates Proliferation , Apoptosis , and Radiosensitivity in Epidermal Growth Factor Receptor Blockade with C 225 Updated

P. Harari, Shyhmin Huang, J. Bock, 1999 .

Epidermal Growth Factor Receptor Blockade with C 225 Modulates Proliferation , Apoptosis , and Radiosensitivity in Squamous Cell Carcinomas of the Head and Neck 1

P. Harari, Shyhmin Huang, J. Bock, 1999 .

Surgical wound healing in advanced head and neck cancer patients undergoing neck dissection following high dose radiation ± cetuximab

P. Harari, J. Myers, J. Bonner, 2003 .

Modulation of radiation response by histone deacetylase inhibition.

P. Harari, P. Chinnaiyan, E. Armstrong, 2005, International journal of radiation oncology, biology, physics.

Effect of insulin-like growth factor 1 receptor inhibitor on sensitization of head and neck cancer cells to cetuximab and methotrexate.

P. Harari, D. Wheeler, H. Hatakeyama, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Targeting HER3-dependent activation of nuclear AKT improves radiotherapy of non-small celllung cancer.

P. Harari, D. Wheeler, M. Iida, 2022, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

The Model of an ASTRO Servant Leader.

P. Harari, T. DeWeese, M. Steinberg, 2021, International journal of radiation oncology, biology, physics.

Nationwide Survey of Patients' Perspectives Regarding Their Radiation and Multidisciplinary Cancer Treatment Experiences.

R. Jagsi, P. Harari, N. Vapiwala, 2019, Journal of oncology practice.

Association of human papillomavirus and p16 status with mucositis and dysphagia for head and neck cancer patients treated with radiotherapy with or without cetuximab: Assessment from a phase 3 registration trial

K. Ang, P. Harari, D. Raben, 2016, European journal of cancer.

Radiation response modification following molecular inhibition of epidermal growth factor receptor signaling.

P. Harari, Shyhmin Huang, S. Huang, 2001, Seminars in radiation oncology.

Partial volume correction improves theranostic 124I/131I-CLR1404 tumor dosimetry in xenograft models of head and neck cancer

P. Harari, B. Bednarz, R. Hernandez, 2022, 2202.06423.

Open the Gates for Treatment De-Intensification in Head and Neck Cancer.

P. Harari, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chondroradionecrosis of the larynx: 24‐year University of Wisconsin experience

P. Harari, G. Hartig, A. Wieland, 2017, Head & neck.

Promising New Approaches in the Treatment of Advanced Head and Neck Cancer

P. Harari, L. Peters, D. Rischin, 2003 .

Head and neck squamous cell carcinoma from an unknown primary site.

P. Harari, W. Mendenhall, C. Morris, 2011, American journal of otolaryngology.

Phase II Randomized Trial of Postoperative Chemoradiation Plus Cetuximab for High-risk Squamous Cell Carcinoma of the Head and Neck (RTOG 0234)

K. Ang, P. Harari, J. Myers, 2009 .

Heat shock stimulates polyamine oxidation by two distinct mechanisms in mammalian cell cultures.

P. Harari, E. Gerner, D. J. Fuller, 1987, International journal of radiation oncology, biology, physics.

Augmentation of radiation response with the vascular targeting agent ZD6126.

P. Harari, J. Eickhoff, E. Armstrong, 2006, International journal of radiation oncology, biology, physics.

Improving dose homogeneity in routine head and neck radiotherapy with custom 3-D compensation.

P. Harari, B. Paliwal, N. Sharda, 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

EGFR-targeting monoclonal antibodies in head and neck cancer.

P. Harari, I. Astsaturov, R. Cohen, 2006, Current cancer drug targets.

Confirmation of improved local-regional control with altered fractionation in head and neck cancer.

J. Fowler, P. Harari, 2000, International journal of radiation oncology, biology, physics.

Clinical outcomes for larynx patients with cancer treated with refinement of high‐dose radiation treatment volumes

P. Harari, M. Witek, T. McCulloch, 2020, Head & neck.

Personalized Treatment for Lacrimal Sac Adenoid Cystic Carcinoma: Case Report and Literature Review.

P. Harari, G. Avey, M. Lucarelli, 2019, Practical radiation oncology.

Increased Oral Mucositis after IMRT versus Non-IMRT when Combined with Cetuximab and Cisplatin or Docetaxel for Head and Neck Cancer: Preliminary Results of RTOG 0234

K. Ang, P. Harari, S. Bentzen, 2008 .

Clinical Implications of Scleroderma in the Decision for Radiotherapy-Based Larynx Preservation.

P. Harari, M. Witek, N. Rydzewski, 2019, JAMA otolaryngology-- head & neck surgery.

Why has induction chemotherapy for advanced head and neck cancer become a United States community standard of practice?

P. Harari, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Polyamine biosynthesis inhibitors combined with systemic hyperthermia in cancer therapy.

P. Harari, E. Gerner, D. Shimm, 1990, International journal of radiation oncology, biology, physics.

Bridging gaps in multidisciplinary head and neck cancer care: nursing coordination and case management.

P. Harari, N. Connor, G. Hartig, 2007, International journal of radiation oncology, biology, physics.

Why So Challenging to Personalize Radiation Dose?

P. Harari, 2017, International journal of radiation oncology, biology, physics.

Dosimetric and Biologic Differences in Flattened and Flattening-Filter-Free Beam Treatment Plans

K. Du, P. Harari, B. Paliwal, 2015, 1506.05152.

Stepwise progress in epidermal growth factor receptor/radiation studies for head and neck cancer.

P. Harari, 2007, International journal of radiation oncology, biology, physics.

Combining Stereotactic Body Radiotherapy and Microwave Ablation Appears Safe and Feasible for Renal Cell Carcinoma in an Early Series.

P. Harari, P. Yadav, S. Wells, 2021, Clinical genitourinary cancer.

Hidradenomas and a Hidradenocarcinoma of the Scalp Managed Using Mohs Micrographic Surgery and a Multidisciplinary Approach: Case Reports and Review of the Literature

P. Harari, S. Snow, G. Hartig, 2009, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Transcriptional-mediated effects of radiation on the expression of immune susceptibility markers in melanoma.

P. Harari, Jasdeep S. Kler, Z. Morris, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Oral tongue cancer in young adults less than 40 years of age: Rationale for aggressive therapy

J. Sarkaria, P. Harari, 1994, Head & neck.

Epidermal growth factor receptor inhibition strategies in oncology.

P M Harari, P. Harari, 2004, Endocrine-related cancer.

The role of radiotherapy in the treatment of malignant sweat gland neoplasms

P. Harari, J. Cassady, D. Shimm, 1990, Cancer.

Radiation‐Induced Angiosarcoma of the Breast: Case Report and Review of the Literature

J. Buatti, P. Harari, J. Cassady, 1994, American journal of clinical oncology.

Precautions in the Use of Intensity-Modulated Radiation Therapy

W. Tomé, J. Welsh, P. Harari, 2005, Technology in cancer research & treatment.

Parotidectomy: Ten-Year Review of 237 Cases at a Single Institution

P. Harari, N. Connor, G. Hartig, 2007, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

Parotid area lymph node metastases from cutaneous squamous cell carcinoma: Implications for diagnosis, treatment, and prognosis

P. Harari, K. Kriesel, G. Hartig, 2005, Head & neck.

Head and Neck Simulation study of high-dose-rate brachytherapy for early glottic cancer

P. Harari, M. Geurts, T. McCulloch, 2016 .

Simulation study of high-dose-rate brachytherapy for early glottic cancer.

P. Harari, M. Geurts, T. McCulloch, 2016, Brachytherapy.

Merkel cell carcinoma. Improved locoregional control with postoperative radiation therapy

A. Graham, P. Harari, J. Cassady, 1991, Cancer.

Patient and tumor characteristics predictive of primary parotid gland malignancy: A 20-year experience at the University of Wisconsin.

P. Harari, T. McCulloch, Sandeep Saha, 2015, American journal of otolaryngology.

Pterygium treated with excision and postoperative beta irradiation.

J. Buatti, P. Harari, J. Cassady, 1992, International journal of radiation oncology, biology, physics.

Helical Tomotherapy: An Innovative Technology and Approach to Radiation Therapy

T. Rockwell Mackie, Rakesh R. Patel, Minesh P. Mehta, 2002, Technology in cancer research & treatment.

Epidermal growth factor receptor blockade with C225 modulates proliferation, apoptosis, and radiosensitivity in squamous cell carcinomas of the head and neck.

P. Harari, Shyhmin Huang, J. Bock, 1999, Cancer research.

Establishment and Characterization of a Model of Acquired Resistance to Epidermal Growth Factor Receptor Targeting Agents in Human Cancer Cells

P. Harari, D. Wheeler, E. Armstrong, 2009, Clinical Cancer Research.

Mechanisms of acquired resistance to cetuximab: role of HER (ErbB) family members

P. Harari, D. Wheeler, T. Kruser, 2008, Oncogene.

Understanding resistance to EGFR inhibitors—impact on future treatment strategies

P. Harari, D. Wheeler, E. F. Dunn, 2010, Nature Reviews Clinical Oncology.

Impact of conventional radiotherapy on health-related quality of life and critical functions of the head and neck.

P. Harari, T. Hong, N. Connor, 2006, International journal of radiation oncology, biology, physics.

Mucoepidermoid carcinoma in a 10‐year‐old girl

P. Harari, M. Cunningham, M. April, 1997, Head & neck.

Megavoltage Computed Tomography: An Emerging Tool for Image-Guided Radiotherapy

Hazim Jaradat, M. Mehta, T. Mackie, 2007, American journal of clinical oncology.

Modulation of radiation response and tumor-induced angiogenesis after epidermal growth factor receptor inhibition by ZD1839 (Iressa).

P. Harari, E. Armstrong, Shyhmin Huang, 2002, Cancer research.

Modulation of radiation response after epidermal growth factor receptor blockade in squamous cell carcinomas: inhibition of damage repair, cell cycle kinetics, and tumor angiogenesis.

P. Harari, Shyhmin Huang, S. Huang, 2000, Clinical Cancer Research.

Dual targeting of EGFR and HER3 with MEHD7945A overcomes acquired resistance to EGFR inhibitors and radiation.

P. Harari, M. Sliwkowski, L. Amler, 2013, Cancer research.

Strategic plans to promote head and neck cancer translational research within the radiation therapy oncology group: a report from the translational research program.

K. Ang, P. Harari, C. Chung, 2007, International journal of radiation oncology, biology, physics.

p53 modulates acquired resistance to EGFR inhibitors and radiation.

P. Harari, D. Wheeler, E. Armstrong, 2011, Cancer research.

Therapeutics , Targets , and Chemical Biology p 53 Modulates Acquired Resistance to EGFR Inhibitors and Radiation

P. Harari, D. Wheeler, E. Armstrong, 2011 .

Establishing quality indicators for neck dissection: Correlating the number of lymph nodes with oncologic outcomes (NRG Oncology RTOG 9501 and RTOG 0234)

M. Suntharalingam, J. Cooper, E. Sturgis, 2016, Cancer.

Multi-institutional trial of accelerated hypofractionated intensity-modulated radiation therapy for early-stage oropharyngeal cancer (RTOG 00-22).

Walter R. Bosch, Avraham Eisbruch, Jones, 2010, International journal of radiation oncology, biology, physics.

Improved survival with dose-escalated radiotherapy in stage III non-small-cell lung cancer: analysis of the National Cancer Database.

P. Harari, A. Amini, M. Witek, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Defining high‐risk elective contralateral neck radiation volumes for oropharynx cancer

P. Harari, M. Witek, P. Yadav, 2021, Head & neck.

Planned Postradiotherapy Neck Dissection: Rationale and Clinical Outcomes

P. Harari, G. Hartig, Gregory M. Richards, 2007, The Laryngoscope.

Molecular target approaches in head and neck cancer: epidermal growth factor receptor and beyond.

J. Grandis, P. Harari, D. Wheeler, 2009, Seminars in radiation oncology.

Dual-Agent Molecular Targeting of the Epidermal Growth Factor Receptor (EGFR)

Prakash Chinnaiyan, P. Harari, Paul M Harari, 2004, Cancer Research.

Epidermal Growth Factor Receptor Inhibition in Cancer Therapy: Biology, Rationale and Preliminary Clinical Results

P. Harari, Shyhmin Huang, 2004, Investigational New Drugs.

Molecular Targeting of Growth Factor Receptor Signaling in Radiation Oncology.

P. Harari, Shyhmin Huang, H. Peter Rodemann, 2016, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

EGFR Signaling and Radiation

P. Harari, Shyhmin Huang, E. F. Dunn, 2011 .

Mechanisms of enhanced radiation response following epidermal growth factor receptor signaling inhibition by erlotinib (Tarceva).

S. Varambally, A. Chinnaiyan, S. Tomlins, 2005, Cancer research.

Small Molecule Inhibition of MDM2–p53 Interaction Augments Radiation Response in Human Tumors

P. Harari, J. Canon, D. Francis, 2015, Molecular Cancer Therapeutics.

Matrix density drives 3D organotypic lymphatic vessel activation in a microfluidic model of the breast tumor microenvironment.

D. Beebe, P. Harari, S. Ponik, 2020, Lab on a chip.

Cetuximab prolongs survival in patients with locoregionally advanced squamous cell carcinoma of head and neck: A phase III study of high dose radiation therapy with or without cetuximab.

Christopher U. Jones, K. Ang, C. Jones, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Biology of interactions: antiepidermal growth factor receptor agents.

P. Harari, J. Bonner, G. Allen, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Longitudinal Molecular Profiling of Circulating Tumor Cells in Metastatic Renal Cell Carcinoma

Jennifer L. Schehr, S. Signoretti, T. Choueiri, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chemoradiation for upper aerodigestive tract cancer: balancing evidence from clinical trials with individual patient recommendations.

M. Mehta, D. Petereit, P. Harari, 2004, Current problems in cancer.

Primary Head and Neck Tumour-Derived Fibroblasts Promote Lymphangiogenesis in a Lymphatic Organotypic Co-culture Model

D. Beebe, P. Harari, S. Ponik, 2021, EBioMedicine.

Augmentation of Radiation Response by Motesanib, a Multikinase Inhibitor that Targets Vascular Endothelial Growth Factor Receptors

J. Bussink, P. Harari, A. Coxon, 2010, Clinical Cancer Research.

Functional preservation and quality of life in head and neck radiotherapy

P. Harari, C. Grau, N. Connor, 2009 .

Tumor Volume as a Prognostic Factor in Oropharyngeal Squamous Cell Carcinoma Treated With Primary Radiotherapy

Mark J. Been, P. Harari, G. Leverson, 2008, The Laryngoscope.

Contributions of Targeted Agents

P. Harari, D. Wheeler, T. Hoang, 2009 .

Combining precision radiotherapy with molecular targeting and immunomodulatory agents: a guideline by the American Society for Radiation Oncology.

J. Sarkaria, K. Camphausen, P. Choyke, 2018, The Lancet. Oncology.

The Relative Expression of Mig6 and EGFR Is Associated with Resistance to EGFR Kinase Inhibitors

S. Goodman, I. Wistuba, M. Hidalgo, 2013, PloS one.

Molecular Targeted Therapies in Head and Neck Cancer

P. Harari, V. Gondi, A. Traynor, 2011 .

Interference with EGFR signaling: paradigm for improving radiation response in cancer treatment

P. Harari, D. Raben, F. Ciardiello, 2002, Expert review of anticancer therapy.

Correlation Between the Severity of Cetuximab-Induced Skin Rash and Clinical Outcome for Head and Neck Cancer Patients: The RTOG Experience.

Christopher U. Jones, A. Garden, P. Harari, 2016, International journal of radiation oncology, biology, physics.

p16 protein expression and human papillomavirus status as prognostic biomarkers of nonoropharyngeal head and neck squamous cell carcinoma.

P. Harari, C. Chung, Q. Zhang, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Enhancement of radiation response with bevacizumab

P. Harari, J. Eickhoff, E. Armstrong, 2012, Journal of experimental & clinical cancer research : CR.

D. Hayes, O. Lichtarge, I. Wistuba, 2022, Advances in Radiation Oncology.

Postoperative chemoradiotherapy and cetuximab for high-risk squamous cell carcinoma of the head and neck: Radiation Therapy Oncology Group RTOG-0234.

K. Ang, P. Harari, Q. Zhang, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The Promise of Combining Radiation Therapy with Immunotherapy.

P. Harari, Z. Morris, J. Jagodinsky, 2020, International journal of radiation oncology, biology, physics.

The Advancement of Epidermal Growth Factor Receptor Inhibitors in Cancer Therapy

P. Harari, G. Allen, 2007 .

Cetuximab and Radiotherapy in Laryngeal Preservation for Cancers of the Larynx and Hypopharynx: A Secondary Analysis of a Randomized Clinical Trial.

P. Harari, S. Spencer, J. Giralt, 2016, JAMA otolaryngology-- head & neck surgery.

COMMENT ON : DISTINGUISHING SECOND PRIMARY TUMORS FROM LUNG METASTASES IN PATIENTS WITH HEAD AND NECK SQUAMOUS CELL CARCINOMA. AUTHORS' REPLY

J. Jen, P. Harari, D. Sidransky, 1998 .

6 – Radiotherapy and Chemotherapy

P. Harari, G. Wilson, P. Chinnaiyan, 2010 .

Identification of phenocopies improves prediction of targeted therapy response over DNA mutations alone

P. Harari, J. Lang, Menggang Yu, 2022, npj Genomic Medicine.

Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab.

Jordi Giralt, K. Ang, P. Harari, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Intensity-modulated radiation therapy: emerging cancer treatment technology

W A Tomé, P M Harari, W. Tomé, 2005, British Journal of Cancer.

Lessons Learned From Hurricane Maria in Puerto Rico: Practical Measures to Mitigate the Impact of a Catastrophic Natural Disaster on Radiation Oncology Patients.

B. Erickson, R. Jagsi, B. Loo, 2019, Practical radiation oncology.

Growth inhibition of squamous cell carcinoma xenografts with the polyamine analogue BE 4444.

P. Harari, M. Pickart, R. P. Qu, 1996, Archives of otolaryngology--head & neck surgery.

Exploitable mechanisms for combining drugs with radiation: concepts, achievements and future directions

P. Harari, J. Bernier, S. Bentzen, 2007, Nature Clinical Practice Oncology.

Functional Outcomes After Transoral Plus Lateral Pharyngotomy Approach for Advanced Oral and Oropharyngeal Tumors

P. Harari, T. Glazer, E. Merfeld, 2023, OTO open.

Cetuximab and bevacizumab: preclinical data and phase II trial in recurrent or metastatic squamous cell carcinoma of the head and neck.

J. Grandis, P. Harari, A. Argiris, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Errors in Description of Suction Required by Patients.

P. Harari, M. Witek, G. Hartig, 2018, JAMA otolaryngology-- head & neck surgery.

Survival Outcomes for Patients With T3N0M0 Squamous Cell Carcinoma of the Glottic Larynx-Reply.

P. Harari, M. Witek, G. Hartig, 2018, JAMA otolaryngology-- head & neck surgery.

Survival Outcomes for Patients With T3N0M0 Squamous Cell Carcinoma of the Glottic Larynx

P. Harari, M. Witek, A. Baschnagel, 2017, JAMA otolaryngology-- head & neck surgery.

Idealized versus realized overall treatment times.

J. Fowler, P. Harari, 1994, International journal of radiation oncology, biology, physics.

Dosimetric differences in flattened and flattening filter-free beam treatment plans

K. Du, P. Harari, B. Paliwal, 2016, Journal of medical physics.

Lymph Node Yield in Therapeutic Neck Dissection: Impact of Dissection Levels and Prior Radiotherapy

P. Harari, T. McCulloch, P. Dang, 2017, The Annals of otology, rhinology, and laryngology.

Patterns of failure for hypopharynx cancer patients treated with limited high-dose radiotherapy treatment volumes

P. Harari, M. Witek, R. Kimple, 2022, Radiation oncology journal.

Immunotherapy Bridge 2016 and Melanoma Bridge 2016: meeting abstracts

C. Croce, L. Fattore, R. Mancini, 2017, Journal of Translational Medicine.

MERTK Mediates Intrinsic and Adaptive Resistance to AXL-targeting Agents

S. Frye, P. Harari, K. Davies, 2018, Molecular Cancer Therapeutics.

Pan-HER Inhibitor Augments Radiation Response in Human Lung and Head and Neck Cancer Models

P. Harari, C. Hullett, R. Kimple, 2015, Clinical Cancer Research.

Targeting epidermal growth factor receptor signaling in the treatment of head and neck cancer

P. Harari, I. Astsaturov, R. Cohen, 2006, Expert review of anticancer therapy.

IMC-C225, an anti-epidermal growth factor receptor monoclonal antibody, for treatment of head and neck cancer

Edward S. Kim, R. Herbst, P. Harari, 2001, Seminars in oncology.

IMC-C225, an anti-epidermal growth factor receptor monoclonal antibody, for treatment of head and neck cancer.

R. Herbst, P. Harari, E. Kim, 2002, Expert opinion on biological therapy.

Antiproliferative effects of N1,N4-dibenzylputrescine in human and rodent tumor cells.

P. Harari, B. Frydman, G. Buldain, 1998, Cellular and molecular biology.

Increased tumor response to neoadjuvant therapy among rectal cancer patients taking angiotensin‐converting enzyme inhibitors or angiotensin receptor blockers

R. Chappell, P. Harari, M. Ritter, 2016, Cancer.

Quality of life in head and neck cancer patients after treatment with high-dose radiotherapy alone or in combination with cetuximab.

K. Ang, P. Harari, J. Jassem, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Epidermal growth factor receptor modulation of radiation response: preclinical and clinical development.

P. Harari, Paul M Harari, Shyhmin Huang, 2002, Seminars in radiation oncology.

Searching for Reliable Epidermal Growth Factor Receptor Response Predictors

P. Harari, Shyhmin Huang, 2004, Clinical Cancer Research.

Targeting AKT/PKB to improve treatment outcomes for solid tumors.

P. Harari, D. Wheeler, M. Iida, 2020, Mutation research.

Enhancing the antitumor activity of ErbB blockade with histone deacetylase (HDAC) inhibition

S. Varambally, A. Chinnaiyan, S. Tomlins, 2006, International journal of cancer.

Chapter 33 – Oropharyngeal Cancer

P. Harari, L. Gentry, D. Adelstein, 2016 .

Impact of p16 status on the results of the phase III cetuximab (cet)/radiotherapy (RT).

K. Ang, P. Harari, D. Raben, 2014 .

986ORANDOMIZED PHASE II STUDY OF MEHD7945A (MEHD) VS CETUXIMAB (CET) IN >= 2ND-LINE RECURRENT/METASTATIC SQUAMOUS CELL CARCINOMA OF THE HEAD & NECK (RMSCCHN) PROGRESSIVE ON/AFTER PLATINUM-BASED CHEMOTHERAPY (PTCT).

A. Jimeno, P. Harari, C. Nutting, 2014, Annals of Oncology.

Intensity-modulated radiation therapy in the management of head and neck cancer

W. Tomé, P. Harari, T. Hong, 2005, Current opinion in oncology.

Correlation of PET images of metabolism, proliferation and hypoxia to characterize tumor phenotype in patients with cancer of the oropharynx.

R. Jeraj, P. Harari, S. Yip, 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Selective omission of level V nodal coverage for patients with oropharyngeal cancer: Clinical validation of intensity‐modulated radiotherapy experience and dosimetric significance

P. Harari, E. Bender, Vatsal B Patel, 2016, Head & neck.

Impact of Node Negative Target Volume Delineation on Contralateral Parotid Gland Dose Sparing Using IMRT in Head and Neck Cancer

P. Harari, W. Magnuson, R. Bayliss, 2015, Technology in cancer research & treatment.

EGFR inhibitors for the treatment of squamous cell carcinoma of the head and neck

P. Harari, R. Mehra, R. Cohen, 2008, Current oncology reports.

Sym004, a Novel Anti-EGFR Antibody Mixture, Augments Radiation Response in Human Lung and Head and Neck Cancers

P. Harari, M. Kragh, E. Armstrong, 2013, Molecular Cancer Therapeutics.

Large Molecule Therapeutics Sym 004 , a Novel Anti-EGFR Antibody Mixture , Augments Radiation Response in Human Lung and Head and Neck Cancers

P. Harari, M. Kragh, E. Armstrong, 2013 .

Epidermal Growth Factor Receptor cooperates with Src Family Kinases in acquired resistance to cetuximab

P. Harari, D. Wheeler, M. Iida, 2009, Cancer biology & therapy.

Clinical Implementation of Adaptive Helical Tomotherapy: A Unique Approach to Image-Guided Intensity Modulated Radiotherapy

Michael Lock, Lisa Forrest, Thomas Rockwell Mackie, 2006, Technology in cancer research & treatment.

Immunocytokine augments local and abscopal response and animal survival when added to radiation and CTLA-4 checkpoint inhibition in a murine melanoma model

P. Harari, A. Korman, S. Gillies, 2015, Journal of Immunotherapy for Cancer.

Immunocytokine Augments the Local and Abscopal Response to Radiation and CTLA4 Checkpoint Inhibition in a Murine Melanoma Model

P. Harari, A. Korman, Z. Morris, 2015 .

Dose intensification in curative head and neck cancer radiotherapy--linear quadratic analysis and preliminary assessment of clinical results.

P M Harari, J F Fowler, J. Fowler, 1993, International journal of radiation oncology, biology, physics.

A clinical-grade liquid biomarker detects neuroendocrine differentiation in prostate cancer

H. Beltran, T. Choueiri, C. Kyriakopoulos, 2022, The Journal of clinical investigation.

Enhanced radiation sensitivity in HPV-positive head and neck cancer.

P. Harari, P. Lambert, R. Kimple, 2013, Cancer research.

Metabolic tumor volume as a prognostic imaging-based biomarker for head-and-neck cancer: pilot results from Radiation Therapy Oncology Group protocol 0522.

Christopher U. Jones, A. Garden, K. Ang, 2015, International Journal of Radiation Oncology, Biology, Physics.

Intensity-modulated radiation therapy in the management of head and neck cancer.

W. Tomé, P. Harari, T. Hong, 2005, Current opinion in oncology.

A Multi-Institutional Experience of MR-Guided Liver Stereotactic Body Radiation Therapy

Minsong Cao, Parag J. Parikh, Rojano Kashani, 2018, Advances in radiation oncology.

Prognostic implications of human papillomavirus status for patients with non-oropharyngeal head and neck squamous cell carcinomas

P. Harari, M. Witek, A. Baschnagel, 2017, Journal of Cancer Research and Clinical Oncology.

Combining polyamine depletion with radiation therapy for rapidly dividing head and neck tumors: strategies for improved locoregional control.

D. Petereit, P. Harari, E. Gerner, 1994, International journal of radiation oncology, biology, physics.

Blocking Y-Box Binding Protein-1 through Simultaneous Targeting of PI3K and MAPK in Triple Negative Breast Cancers

P. Harari, M. Schaller, D. Zips, 2020, Cancers.

OC-0211: Real-time MRI-guided Radiotherapy for pancreatic cancer

P. Harari, M. Geurts, C. Hullett, 2016 .

Biologic basis for combining drugs with radiation.

George D Wilson, Søren M Bentzen, P. Harari, 2006, Seminars in radiation oncology.

Clinical promise tempered by reality in the delivery of combined chemoradiation for common solid tumors.

M. Mehta, D. Petereit, P. Harari, 2003, Seminars in radiation oncology.

Advances in radiation therapy for head and neck cancer

P. Harari, T. Kinsella, 1995, Current opinion in oncology.

Evolutionary action score of TP53 analysis in pathologically high-risk HPV-negative head and neck cancer from a phase II clinical trial: NRG Oncology RTOG 0234.

D. Hayes, O. Lichtarge, I. Wistuba, 2019, Journal of Clinical Oncology.

Randomized Phase II Study of Duligotuzumab (MEHD7945A) vs. Cetuximab in Squamous Cell Carcinoma of the Head and Neck (MEHGAN Study)

A. Jimeno, P. Harari, C. Nutting, 2016, Front. Oncol..

Radiosensitization of Adenoid Cystic Carcinoma with MDM2 Inhibition

P. Harari, I. Ong, J. Canon, 2017, Clinical Cancer Research.

Intubation granuloma of the larynx: Successful eradication with low‐dose radiotherapy

P. Harari, S. Coulthard, J. R. Cassady, 1991, Head & neck.

Quantitative evaluation of image segmentation incorporating medical consideration functions.

Min Yao, Jason W Sohn, Mitchell Machtay, 2015, Medical physics.

Fibroblast Growth Factor Receptors as Targets for Radiosensitization in Head and Neck Squamous Cell Carcinomas.

Michael M. Fisher, P. Harari, I. Ong, 2020, International journal of radiation oncology, biology, physics.

Chapter 31 – Oropharyngeal Cancer

P. Harari, L. Siu, G. Avey, 2012 .

Antitumor Effects of MEHD7945A, a Dual-Specific Antibody against EGFR and HER3, in Combination with Radiation in Lung and Head and Neck Cancers

P. Harari, M. Sliwkowski, A. J. van der Kogel, 2015, Molecular Cancer Therapeutics.

Gadoxetate for direct tumor therapy and tracking with real-time MRI-guided stereotactic body radiation therapy of the liver.

P. Harari, B. Paliwal, M. Geurts, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

When Disaster Strikes: Mitigating the Adverse Impact on Head and Neck Cancer Patients.

P. Harari, S. Yom, 2018, International journal of radiation oncology, biology, physics.

Utilization and outcomes of low dose versus high dose cisplatin in head and neck cancer patients receiving concurrent radiation.

Amy Y. Chen, A. Garden, W. Curran, 2015 .

Establishment of acquired resistance to epidermal growth factor receptor (EGFR) inhibitors in human tumor cell lines

P. Harari, P. Chinnaiyan, E. Armstrong, 2004 .

Radiation combined with EGFR signal inhibitors: head and neck cancer focus.

P. Harari, Shyhmin Huang, 2006, Seminars in radiation oncology.

HPV impacts survival of stage IVC non-oropharyngeal HNSCC cancer patients

P. Harari, M. Witek, A. Baschnagel, 2018, Otorhinolaryngology-head and neck surgery.

Lessons Learned from Hurricane Maria in Puerto Rico: Practical Measures to Mitigate the Impact of a Catastrophic Natural Disaster on Radiation Oncology Patients

B. Erickson, R. Jagsi, B. Loo, 2019, International Journal of Radiation Oncology*Biology*Physics.

A comprehensive assessment by tumor site of patient setup using daily MVCT imaging from more than 3,800 helical tomotherapy treatments.

Bhudatt R Paliwal, Deepak Khuntia, Thomas R Mackie, 2009, International journal of radiation oncology, biology, physics.

Acute radiation reactions in oral and pharyngeal mucosa: tolerable levels in altered fractionation schedules.

J. Fowler, P. Harari, J. Leborgne, 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Xenograft assessment of predictive biomarkers for standard head and neck cancer therapies

P. Harari, P. Lambert, R. Kimple, 2015, Cancer medicine.

Evaluation and quality control of a commercial 3-D dose compensator system.

M B Podgorsak, B R Paliwal, P M Harari, 1994, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

Microphysiological head and neck cancer model identifies novel role of lymphatically secreted monocyte migration inhibitory factor in cancer cell migration and metabolism.

D. Beebe, P. Harari, M. Skala, 2023, Biomaterials.

Identification of stable housekeeping genes in response to ionizing radiation in cancer research

Gopal Iyer, P. Harari, Paul M. Harari, 2017, Scientific Reports.

Fragmentomic analysis of circulating tumor DNA targeted cancer panels.

M. Burkard, A. Wyatt, H. Beltran, 2023, Annals of oncology : official journal of the European Society for Medical Oncology.

Polyamine catabolism in rodent and human cells in culture.

P. Harari, E. Gerner, S. Carper, 1991, The Biochemical journal.

Declining Medical Student Interest in Radiation Oncology - Wake-up Call with a Silver Lining?

P. Harari, N. Vapiwala, J. Brower, 2021, International journal of radiation oncology, biology, physics.

Why an Increasing Number of Unmatched Residency Positions in Radiation Oncology? A Survey of Fourth-Year Medical Students

J. Buatti, P. Harari, J. Stahl, 2021, Advances in radiation oncology.

Long-term Outcomes of Bevacizumab and Chemoradiation for Locoregionally Advanced Nasopharyngeal Carcinoma

A. Garden, J. Mechalakos, P. Harari, 2023, JAMA network open.

Insulin growth factor 1 like receptor (IGF-1R)

P. Harari, E. Armstrong, Shyhmin Huang, 2016, BMC Cancer.

Erratum to: Insulin-like growth factor 1 receptor mediated tyrosine 845 phosphorylation of epidermal growth factor receptor in the presence of monoclonal antibody cetuximab

P. Harari, E. Armstrong, Shyhmin Huang, 2016, BMC Cancer.

Refining guidelines regarding unilateral treatment in patients with well-lateralized squamous cell carcinoma of the palatine tonsil and multiple positive nodes or extranodal extension.

P. Harari, W. Mendenhall, R. Amdur, 2021, Practical Radiation Oncology.

p16 expression as a human papillomavirus (HPV)-independent prognostic biomarker in non-oropharyngeal squamous cell carcinoma (non-OPSCC).

K. Ang, P. Harari, C. Chung, 2013 .

Epidermal Growth Factor Receptor Blockade with C 225 Modulates Proliferation , Apoptosis , and Radiosensitivity in Squamous Cell Carcinomas of the Head and Neck 1

P. Harari, Shyhmin Huang, J. Bock, 1999 .

Development of scanned focussed ultrasound hyperthermia: clinical response evaluation.

K. Hynynen, R. Roemer, P. Harari, 1991, International journal of radiation oncology, biology, physics.

Impact of HPV Status on the Prognostic Potential of the AJCC Staging System for Larynx Cancer

P. Harari, M. Witek, A. Baschnagel, 2018, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

Longitudinal Oncology Registry of Head and Neck Carcinoma (LORHAN), a new national cancer registry.

K. Ang, P. Harari, B. Murphy, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Validation of Monte Carlo 131I radiopharmaceutical dosimetry workflow using a 3D‐printed anthropomorphic head and neck phantom

P. Harari, B. Bednarz, B. Cox, 2022, Medical physics.

Therapeutic combination of radiolabeled CLR1404 with external beam radiation in head and neck cancer model systems.

P. Harari, B. Bednarz, R. Kimple, 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

The Relationship of Cetuximab-Induced Rash and Survival in Patients with Head and Neck Cancer Treated with Radiotherapy and Cetuximab

K. Ang, J. Baselga, P. Harari, 2005 .

MO‐E‐AUD C‐03: Use of FLT‐PET Imaging to Assess Tumor and Normal Tissue Response to Radiotherapy

M. Mehta, R. Jeraj, P. Harari, 2008 .

Gender associations in head and neck squamous cell carcinoma (HNSCC).

P. Harari, Menggang Yu, T. McCulloch, 2012 .

345 EGFR therapies with radiation (the head and neck data)

P. Harari, 2003 .

Insulin growth factor 1 like receptor (IGF-1R)

P. Harari, E. Armstrong, Shyhmin Huang, 2016, BMC Cancer.

A New Era of Image Guidance with Magnetic Resonance-guided Radiation Therapy for Abdominal and Thoracic Malignancies

John E Bayouth, Zacariah E Labby, Stephen Rosenberg, 2018, Cureus.

Phase II Randomized Trial of Surgery Followed by Chemoradiation Plus Cetuximab for High-Risk Squamous Cell Carcinoma of the Head and Neck (RTOG 0234)

K. Ang, P. Harari, J. Myers, 2007 .

Molecular and Cellular Pathobiology Enhanced Radiation Sensitivity in HPV-Positive Head and Neck Cancer

P. Harari, P. Lambert, R. Kimple, 2013 .

Emphasizing conformal avoidance versus target definition for IMRT planning in head-and-neck cancer.

Wolfgang A. Tome, Shiyu Song, W. Tomé, 2010, International journal of radiation oncology, biology, physics.

Stress Keratin 17 Expression in Head and Neck Cancer Contributes to Immune Evasion and Resistance to Immune-Checkpoint Blockade.

P. Harari, Huy Q. Dinh, P. Lambert, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

Dual Axl/MerTK inhibitor INCB081776 creates a proinflammatory tumor immune microenvironment and enhances anti‐PDL1 efficacy in head and neck cancer

P. Harari, R. Birge, Menggang Yu, 2023, Head & neck.

ACCO: ASCO core curriculum outline.

J. V. Von Roenn, L. Deangelis, P. Harari, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Combining precision radiotherapy with molecular targeting and immunomodulatory agents: a guideline by the American Society for Radiation Oncology.

J. Sarkaria, K. Camphausen, P. Choyke, 2018, The Lancet. Oncology.

Small Molecule Inhibition of MDM2–p53 Interaction Augments Radiation Response in Human Tumors

P. Harari, J. Canon, D. Francis, 2015, Molecular Cancer Therapeutics.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

Charles J. Vaske, Joe Y. Chang, Scott R. Presnell, 2016, Journal for ImmunoTherapy of Cancer.

Abstract 637: MEHD7945A, an EGFR/ErbB3 dual specific antibody, overcomes acquired resistance to EGFR inhibitors in head and neck and lung tumors

P. Harari, M. Sliwkowski, Shyhmin Huang, 2011 .

Head and neck squamous cell carcinoma from an unknown primary site.

P. Harari, W. Mendenhall, C. Morris, 2011, American journal of otolaryngology.

Small Molecule Inhibition of MERTK Is Efficacious in Non–Small Cell Lung Cancer Models Independent of Driver Oncogene Status

S. Frye, B. Hendriks, P. Harari, 2015, Molecular Cancer Therapeutics.

Monoclonal antibody blockade of the epidermal growth factor receptor in cancer therapy.

P. Harari, Jian Li, S. Huang, 2001, Cancer chemotherapy and biological response modifiers.

Targeting of Head and Neck Cancer by Radioiodinated CLR1404 in Murine Xenograft Tumor Models with Partial Volume Corrected Theranostic Dosimetry.

P. Harari, B. Bednarz, R. Hernandez, 2023, Cancer biotherapy & radiopharmaceuticals.

Interstitial Brachytherapy for Lip Cancer: Technical Aspects to Individualize Treatment Approach and Optimize Outcomes.

P. Harari, M. Witek, T. McCulloch, 2023, Practical radiation oncology.

Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial

Christopher U. Jones, E. Sturgis, P. Harari, 2019, The Lancet.

Scanned focussed ultrasound hyperthermia: Clinical response evaluation

K. Hynynen, R. Roemer, P. Harari, 1990 .

Correlation Between the Severity of Cetuximab-Induced Skin Rash and Clinical Outcome for Head and Neck Cancer Patients: The RTOG Experience.

Christopher U. Jones, A. Garden, P. Harari, 2016, International journal of radiation oncology, biology, physics.

Head and Neck Cancer

P. Harari, A. Psyrri, B. Burtness, 2010, Journal of oncology.

Nodal Metastasis Count and Oncologic Outcomes in Head and Neck Cancer: A Secondary Analysis of NRG/RTOG 9501, NRG/RTOG 0234, and EORTC 22931.

M. Luu, J. Cooper, P. Harari, 2022, International journal of radiation oncology, biology, physics.